215 related articles for article (PubMed ID: 23765204)
1. Association of CXC chemokine receptor type 4 expression and clinicopathologic features in human vulvar cancer.
Shiozaki T; Tabata T; Ma N; Yamawaki T; Motohashi T; Kondo E; Tanida K; Okugawa T; Ikeda T
Int J Gynecol Cancer; 2013 Jul; 23(6):1111-7. PubMed ID: 23765204
[TBL] [Abstract][Full Text] [Related]
2. Stage IA vulvar squamous cell carcinoma: an analysis of tumor invasive characteristics and risk.
Yoder BJ; Rufforny I; Massoll NA; Wilkinson EJ
Am J Surg Pathol; 2008 May; 32(5):765-72. PubMed ID: 18379417
[TBL] [Abstract][Full Text] [Related]
3. Expression of vascular endothelial growth factors VEGF- C and D, VEGFR-3, and comparison of lymphatic vessels density labeled with D2-40 antibodies as a prognostic factors in vulvar intraepithelial neoplasia (VIN) and invasive vulvar cancer.
Jach R; Dyduch G; Radon-Pokracka M; Przybylska P; Mika M; Dulinska-Litewka J; Zajac K; Huras H; Streb J; Stangel-Wojcikiewicz K; Dziadek O; Galarowicz B
Neuro Endocrinol Lett; 2011; 32(4):530-9. PubMed ID: 21876509
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value and clinicopathologic characteristics of L1 cell adhesion molecule (L1CAM) in a large series of vulvar squamous cell carcinomas.
Trietsch MD; Oonk MH; Hawinkels LJ; Bor R; van Eendenburg JD; Ivanova Z; Peters AA; Nijman HW; Gaarenstroom KN; Bosse T
Oncotarget; 2016 May; 7(18):26192-205. PubMed ID: 27028855
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance and prognostic value of femoral lymph node metastasis in FIGO stage III vulvar carcinoma.
Tu H; Sun P; Gu HF; Zhang XK; Huang H; Wan T; Liu JH
Eur J Surg Oncol; 2017 Sep; 43(9):1768-1775. PubMed ID: 28602173
[TBL] [Abstract][Full Text] [Related]
6. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
7. Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancer.
Tantipalakorn C; Robertson G; Marsden DE; Gebski V; Hacker NF
Obstet Gynecol; 2009 Apr; 113(4):895-901. PubMed ID: 19305336
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 and CD1a-positive dendritic cells are involved in the development of an invasive phenotype in vulvar squamous lesions.
Brustmann H
Int J Gynecol Pathol; 2006 Jan; 25(1):30-7. PubMed ID: 16306781
[TBL] [Abstract][Full Text] [Related]
9. immunohistochemical expression of survivin and γ-H2AX in vulvar intraepithelial neoplasia and low-stage squamous cell carcinoma.
Brustmann H; Hinterholzer S; Brunner A
Int J Gynecol Pathol; 2011 Nov; 30(6):583-90. PubMed ID: 21979596
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of SOX2 in vulvar intraepithelial neoplasia and squamous cell carcinoma.
Brustmann H; Brunner A
Int J Gynecol Pathol; 2013 May; 32(3):323-8. PubMed ID: 23518916
[TBL] [Abstract][Full Text] [Related]
11. Vulvar squamous cell carcinoma. Prognostic factors for local recurrence after primary en bloc radical vulvectomy and bilateral groin dissection.
Fonseca-Moutinho JA; Coelho MC; Silva DP
J Reprod Med; 2000 Aug; 45(8):672-8. PubMed ID: 10986688
[TBL] [Abstract][Full Text] [Related]
12. Increased osteopontin expression is associated with progression from vulvar precancerous lesions to vulvar squamous cell carcinoma.
Wu Z; Shen Y; Gong K; Wu Z; Zhang T; Zhang X; Li S
Arch Gynecol Obstet; 2014 Mar; 289(3):637-44. PubMed ID: 23978873
[TBL] [Abstract][Full Text] [Related]
13. Expression of ZNF652, a novel zinc finger protein, in vulvar carcinomas and its relation to prognosis.
Holm R; Knopp S; Kumar R; Lee J; Nesland JM; Tropè C; Callen DF
J Clin Pathol; 2008 Jan; 61(1):59-63. PubMed ID: 17468294
[TBL] [Abstract][Full Text] [Related]
14. High levels of p53 expression correlate with DNA aneuploidy in (pre)malignancies of the vulva.
van der Avoort IA; van de Nieuwenhof HP; Otte-Höller I; Nirmala E; Bulten J; Massuger LF; van der Laak JA; Slootweg PJ; de Hullu JA; van Kempen LC
Hum Pathol; 2010 Oct; 41(10):1475-85. PubMed ID: 20656324
[TBL] [Abstract][Full Text] [Related]
15. Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer.
Kodama J; Hasengaowa ; Kusumoto T; Seki N; Matsuo T; Ojima Y; Nakamura K; Hongo A; Hiramatsu Y
Ann Oncol; 2007 Jan; 18(1):70-76. PubMed ID: 17032700
[TBL] [Abstract][Full Text] [Related]
16. Expression of EphA2 and EphrinA-1 in vulvar carcinomas and its relation to prognosis.
Holm R; Knopp S; Suo Z; Tropè C; Nesland JM
J Clin Pathol; 2007 Oct; 60(10):1086-91. PubMed ID: 17158642
[TBL] [Abstract][Full Text] [Related]
17. CXCR4 overexpression is associated with poor outcome in females diagnosed with stage IV non-small cell lung cancer.
Otsuka S; Klimowicz AC; Kopciuk K; Petrillo SK; Konno M; Hao D; Muzik H; Stolte E; Boland W; Morris D; Magliocco AM; Bebb DG
J Thorac Oncol; 2011 Jul; 6(7):1169-78. PubMed ID: 21623238
[TBL] [Abstract][Full Text] [Related]
18. Expression of human telomerase reverse transcriptase in vulvar intraepithelial neoplasia and squamous cell carcinoma: an immunohistochemical study with survivin and p53.
Wellenhofer A; Brustmann H
Arch Pathol Lab Med; 2012 Nov; 136(11):1359-65. PubMed ID: 23106581
[TBL] [Abstract][Full Text] [Related]
19. The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned.
van de Nieuwenhof HP; van Kempen LC; de Hullu JA; Bekkers RL; Bulten J; Melchers WJ; Massuger LF
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2061-7. PubMed ID: 19567503
[TBL] [Abstract][Full Text] [Related]
20. [Recent prognostic factors in vulvar carcinoma: histological, immunohistochemical and flow cytometry studies].
Weikel W; Beck T; Moll R; Brumm C; Knapstein PG
Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():11-4. PubMed ID: 8672907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
